CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study.
Khandelwal, P; Fukuda, T; Teusink-Cross, A; Kashuba, AD M; Lane, A; Mehta, PA; Marsh, RA; Jordan, MB; Grimley, MS; Myers, KC; et al.
Bone Marrow Transplantation.
2020;
55:1552-1559.
Ibrutinib for the treatment of chronic graft-vs-host disease in pediatric hematopoietic stem cell transplant patients: A single-center experience.
Teusink-Cross, A; Davies, SM; Grimley, MS; Chandra, S; Flannery, A; Dandoy, CE; Nelson, AS; Marsh, RA; Jacoby, B; Lane, A; et al.
Pediatric Transplantation.
2020;
24.
CD38brightCD8+ T Cells Associated with the Development of Acute GVHD Are Activated, Proliferating, and Cytotoxic Trafficking Cells.
Khandelwal, P; Chaturvedi, V; Owsley, E; Lane, A; Heyenbruch, D; Lutzko, CM; Leemhuis, T; Grimley, MS; Nelson, AS; Davies, SM; et al.
Biology of Blood and Marrow Transplantation.
2020;
26:1-6.
A Pilot Study of Human Milk to Reduce Intestinal Inflammation After Bone Marrow Transplant.
Khandelwal, P; Andersen, H; Romick-Rosendale, L; Taggart, CB; Watanabe, M; Lane, A; Dandoy, CE; Lake, KE; Litts, BA; Morrow, AL; et al.
Breastfeeding Medicine.
2019;
14:193-202.
Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.
Khandelwal, P; Millard, HR; Thiel, E; Abdel-Azim, H; Abraham, AA; Auletta, JJ; Boulad, F; Brown, VI; Camitta, BM; Chan, KW; et al.
Biology of Blood and Marrow Transplantation.
2017;
23:1342-1349.
Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.
Khandelwal, P; Teusink-Cross, A; Davies, SM; Nelson, AS; Dandoy, CE; El-Bietar, J; Marsh, RA; Kumar, AR; Grimley, MS; Jodele, S; et al.
Biology of Blood and Marrow Transplantation.
2017;
23:1122-1127.
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.
Khandelwal, P; Emoto, C; Fukuda, T; Vinks, AA; Neumeier, L; Dandoy, CE; El-Bietar, J; Chandra, S; Davies, SM; Bleesing, JJ; et al.
Biology of Blood and Marrow Transplantation.
2016;
22:2220-2225.
A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease.
Khandelwal, P; Bleesing, JJ; Davies, SM; Marsh, RA.
Biology of Blood and Marrow Transplantation.
2016;
22:2011-2018.
A Pharmacokinetic and Pharmacodynamic Study of Maraviroc as Acute Graft-versus-Host Disease Prophylaxis in Pediatric Allogeneic Stem Cell Transplant Recipients with Nonmalignant Diagnoses.
Khandelwal, P; Fukuda, T; Mizuno, K; Teusink-Cross, A; Mehta, PA; Marsh, RA; Kashuba, AD M; Vinks, AA; Davies, SM.
Biology of Blood and Marrow Transplantation.
2016;
22:1829-1835.
Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndrome.
Khandelwal, P; Gupta, A; Sinha, A; Saini, S; Hari, P; Dragon Durey, M; Bagga, A.
Pediatric Nephrology.
2015;
30:451-457.